# A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions

> **NCT06894329** · — · RECRUITING · sponsor: **Amplified Sciences Inc** · enrollment: 50 (estimated)

## Conditions studied

- Pancreatic Cystic Lesions

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06894329
- **Lead sponsor:** Amplified Sciences Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-17
- **Primary completion:** 2026-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06894329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06894329, "A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06894329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*